UBIAD1 antibody (AA 32-45)

Catalog No. ABIN289551

Product Details anti-UBIAD1 Antibody

Target: UBIAD1 (UbiA Prenyltransferase Domain Containing 1 (UBIAD1))

Binding Specificity: AA 32-45

Reactivity: Human

Host: Rabbit

Clonality: Polyclonal

Conjugate: This UBIAD1 antibody is un-conjugated

Application: Western Blotting (WB)

Cross-Reactivity (Details): This antibodys immunogen sequence shares 85 % sequence identity with both the Mouse and rat homologs.

Purification: Affinity chromatography purified

Immunogen: TERE1 antibody was raised in rabbit using AA 32-45 [PEQDRLPQRSWRQK] of the 37 kDa human TERE1 protein as the immunogen.

Isotype: IgG

Application Details

Application Notes: WB:1:500
Optimal conditions should be determined by the investigator.

Restrictions: For Research Use only

Handling

Concentration: Lot specific

Buffer: Affinity purified and supplied in PBS, with 0.02 % NaN3.

Preservative: Sodium azide

Precaution of Use: This product contains Sodium Azide: a POISONOUS AND HAZARDOUS SUBSTANCE, which should be handled by trained staff only.

Handling Advice: Avoid repeated freeze/thaw cycles.
Dilute only prior to immediate use.

Storage: 4 °C/-20 °C

Storage Comment: Store at 4 °C for short term storage. Aliquot and store at -20 °C for long term storage.

Target Details for UBIAD1

Target: UBIAD1 (UbiA Prenyltransferase Domain Containing 1 (UBIAD1))

Alternative Name: TERE1 (UBIAD1 Products)

Synonyms: UBIAD1 antibody, wu:fc30e12 antibody, RP4-796F18.1 antibody, SCCD antibody, TERE1 antibody, 1200002M06Rik antibody, AI426463 antibody, AW320947 antibody, Tere1 antibody, RGD1309588 antibody, UbiA prenyltransferase domain containing 1 antibody, UBIAD1 antibody, ubiad1 antibody, Ubiad1 antibody

Background: A novel gene designated TERE1, has a significant effect on the growth regulation in bladder cancer. The TERE1 gene maps to a chromosome locus that has been identified by loss of heterozygosity studies as a site of a putative tumor suppressor gene or genes for multiple tumor types including prostate carcinoma.